24 March 2016 | Statements

Unitaid chair appeals for publicly funded research to defeat TB

Unitaid’s Chair Philippe Douste-Blazy has appealed for more public funding of research to help defeat tuberculosis, a disease which kills 1.5 million people every year.

“Left to their own devices, market forces will not deliver the solutions that the world needs,” Dr Douste-Blazy said in an article in the Guardian published on World TB Day. “The international community must do more to support public funding of research. Their support can play a catalytic role in helping to defeat this ancient scourge, which is still one of the most lethal infectious diseases.”

Dr Douste-Blazy also said that resistance to TB medicines threatens to stall, or even to reverse, progress in the fight against the disease unless shorter, more effective treatment regimens were introduced.

“If left unchecked, these trends could derail plans to cut TB deaths by 95% in the next 20 years, as enshrined in the World Health Organisation’s global strategy,” said Dr Douste-Blazy.

Calling for innovative ideas to help change the trajectory of the pandemic, he concluded: “We can make it happen together, working with the private and public sector. We can turn the tide against tuberculosis.”

Read more:14,600 pills over two years – there has to be a better way to treat TB” – The Guardian

View All News

Featured News

02 July 2020

ACT-Accelerator moves to expand access to dexamethasone for low- and middle-income countries for COVID-19 treatment

Read More

22 June 2020

£2.2m for Liverpool-led initiative to rapidly identify COVID-19 ‘game changing’ drugs

Read More

Sign Up for Unitaid Updates

  • This field is for validation purposes and should be left unchanged.